1 |
Rozenbaum M, Boulman N, Slobodin G, et al. Behcet disease in adult Druzes in north Israel: the influence of ethnic origin on disease expression and severity. J Clin Rheumatol 2007;13:124-127.
DOI
|
2 |
Bang DS, Oh SH, Lee KH, Lee ES, Lee SN. Influence of sex on patients with Behcet's disease in Korea. J Korean Med Sci 2003;18:231-235.
DOI
|
3 |
Shang Y, Han S, Li J, Ren Q, Song F, Chen H. The clinical feature of Behcet's disease in Northeastern China. Yonsei Med J 2009;50:630-636.
DOI
|
4 |
Davatchi F, Shahram F, Chams C, et al. The influence of gender on the frequency of clinical symptoms in Behcet's disease. Adv Exp Med Biol 2003;528:65-66.
|
5 |
Tursen U, Gurler A, Boyvat A. Evaluation of clinical findings according to sex in 2313 Turkish patients with Behcet's disease. Int J Dermatol 2003;42:346-351.
DOI
|
6 |
Zouboulis CC, Vaiopoulos G, Marcomichelakis N, et al. Onset signs, clinical course, prognosis, treatment and outcome of adult patients with Adamantiades-Behcet's disease in Greece. Clin Exp Rheumatol 2003;21(4 Suppl 30):S19-S26.
|
7 |
Saricaoglu H, Karadogan SK, Bayazit N, Yucel A, Dilek K, Tunali S. Clinical features of late-onset Behcet's disease: report of nine cases. Int J Dermatol 2006;45:1284-1287.
DOI
|
8 |
Tsai J, Chen GS, Lu YW, Wu CS, Lan CC. Late-onset Behcet's disease does not correlate with indolent clinical course: report of seven Taiwanese patients. J Eur Acad Dermatol Venereol 2008;22:596-600.
DOI
|
9 |
Sungur G, Hazirolan D, Hekimoglu E, Kasim R, Duman S. Late-onset Behcet's disease: demographic, clinical, and ocular features. Graefes Arch Clin Exp Ophthalmol 2010;248:1325-1330.
DOI
|
10 |
Alpsoy E, Elpek GO, Yilmaz F, et al. Androgen receptor levels of oral and genital ulcers and skin pathergy test in patients with Behcet's disease. Dermatology 2005;210:31-35.
DOI
|
11 |
Atasoy M, Karatay S, Yildirim K, Kadi M, Erdem T, Senel K. The relationship between serum prolactin levels and disease activity in patients with Behcet's disease. Cell Biochem Funct 2006;24:353-356.
DOI
|
12 |
Hazirolan D, Sungur G, Duman S. Demographic, clinical, and ocular features in patients with late-onset Behcet disease. Ocul Immunol Inflamm 2012;20:119-124.
DOI
|
13 |
Alpsoy E, Donmez L, Onder M, et al. Clinical features and natural course of Behcet's disease in 661 cases: a multicentre study. Br J Dermatol 2007;157:901-906.
DOI
|
14 |
Hamuryudan V, Hatemi G, Tascilar K, et al. Prognosis of Behcet's syndrome among men with mucocutaneous involvement at disease onset: long-term outcome of patients enrolled in a controlled trial. Rheumatology (Oxford) 2010;49:173-177.
DOI
|
15 |
Hamzaoui A, Jaziri F, Ben Salem T, et al. Comparison of clinical features of Behcet disease according to age in a Tunisian cohort. Acta Med Iran 2014;52:748-751.
|
16 |
Wallace GR. HLA-B*51 the primary risk in Behcet disease. Proc Natl Acad Sci U S A 2014;111:8706-8707.
DOI
|
17 |
Maldini C, Lavalley MP, Cheminant M, de Menthon M, Mahr A. Relationships of HLA-B51 or B5 genotype with Behcet's disease clinical characteristics: systematic review and meta-analyses of observational studies. Rheumatology (Oxford) 2012;51:887-900.
DOI
|
18 |
Chang HK, Kim JU, Cheon KS, Chung HR, Lee KW, Lee IH. HLA-B51 and its allelic types in association with Behcet's disease and recurrent aphthous stomatitis in Korea. Clin Exp Rheumatol 2001;19(5 Suppl 24):S31-S35.
|
19 |
Hamzaoui A, Houman MH, Massouadia M, et al. Contribution of Hla-B51 in the susceptibility and specific clinical features of Behcet's disease in Tunisian patients. Eur J Intern Med 2012;23:347-349.
DOI
|
20 |
International Team for the Revision of the International Criteria for Behcet's Disease (ITR-ICBD). The International Criteria for Behcet's Disease (ICBD): a collaborative study of 27 countries on the sensitivity and specificity of the new criteria. J Eur Acad Dermatol Venereol 2014;28:338-347.
DOI
|
21 |
Sieper J, van der Heijde D, Landewe R, et al. New criteria for inflammatory back pain in patients with chronic back pain: a real patient exercise by experts from the Assessment of SpondyloArthritis international Society (ASAS). Ann Rheum Dis 2009;68:784-788.
DOI
|
22 |
Kalra S, Silman A, Akman-Demir G, et al. Diagnosis and management of Neuro-Behcet's disease: international consensus recommendations. J Neurol 2014;261:1662-1676.
DOI
|
23 |
International Study Group for Behcet's Disease. Criteria for diagnosis of Behcet's disease. Lancet 1990;335:1078-1080.
|
24 |
Behcet's Disease Research Committee of Japan. Behcet's disease guide to the diagnosis of Behcet's disease (1972). Jpn J Ophthalmol 1974;18:291-294.
|
25 |
Onder M, Gurer MA. The multiple faces of Behcet's disease and its aetiological factors. J Eur Acad Dermatol Venereol 2001;15:126-136.
DOI
|
26 |
Davatchi F, Shahram F, Chams C, Chams H, Nadji A. Behcet's disease. Acta Med Iran 2005;43:233-242.
|
27 |
Khairallah M, Accorinti M, Muccioli C, Kahloun R, Kempen JH. Epidemiology of Behcet disease. Ocul Immunol Inflamm 2012;20:324-335.
DOI
|
28 |
Kaklamani VG, Vaiopoulos G, Kaklamanis PG. Behcet's disease. Semin Arthritis Rheum 1998;27:197-217.
DOI
|
29 |
Davatchi F, Shahram F, Chams-Davatchi C, et al. Behcet's disease: from East to West. Clin Rheumatol 2010;29:823-833.
DOI
|
30 |
Davatchi F, Shahram F, Nadji A, et al. Performance of existing diagnosis/classification criteria for Behcet's disease in Iranian patients: analysis of 5666 patients and 2406 controls. APLAR J Rheum 2006;9:238-243.
DOI
|
31 |
Davatchi F, Sadeghi Abdollahi B, Shahram F, et al. Validation of the international criteria for Behcet's disease (ICBD) in Iran. Int J Rheum Dis 2010;13:55-60.
DOI
|
32 |
Krause I, Yankevich A, Fraser A, et al. Prevalence and clinical aspects of Behcet's disease in the north of Israel. Clin Rheumatol 2007;26:555-560.
DOI
|
33 |
Kotevoglu N. Coexistence of ankylosing spondylitis and Behcet's disease: two cases with atypical presentation and course. Scand J Rheumatol 2003;32:184-185.
DOI
|
34 |
Cimen OB, Sahin G, Bicer A, Erdogan C. Behcet's syndrome coexisting with clinically occult ankylosing spondylitis. Z Rheumatol 2002;61:440-442.
DOI
|
35 |
Yavuz S, Ozilhan G, Elbir Y, Tolunay A, Eksioglu-Demiralp E, Direskeneli H. Activation of neutrophils by testosterone in Behcet's disease. Clin Exp Rheumatol 2007;25(4 Suppl 45):S46-S51.
|
36 |
Krause I, Mader R, Sulkes J, et al. Behcet's disease in Israel: the influence of ethnic origin on disease expression and severity. J Rheumatol 2001;28:1033-1036.
|